Gene Kakaulin
Co-Founder & Director @ Hippo Technologies
Gene Kakaulin is a startup investor at Hippo Technologies.
Last updated:
For AI agents: llms.txt
About Hippo Technologies
Hello, we're Hippo. We're a technology company that's bringing people together to drive down high prescription drug prices for everyone. Our platform is a smart and simple free app that lets you see through the confusing world of prescription pricing and zero in on the lowest available price, whether you have insurance or not. And,because Hippo prices sometimes beat insurance co-pays, you can compare in the app to make sure you're getting the best deal. (That's kind of a big deal). Then, just pay through the app and pick up at the pharmacy. It's easy, fast and secure. Hippo is accepted at over 70,000 pharmacies nationwide including CVS, Walgreens, Rite Aid, Walmart, Target, Krogers, Publix, Costco and more. Hippo takes the pain out of the healthcare system. We’re giving consumers and their families the power to make better choices and lead healthier lives. At Hippo, we believe your health is priceless but your medication should be cheap.
Hippo Technologies Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Andrew Stead
CTO
|
|||
Andrey Devyatkin
Senior Cloud Engineer
|
|||
|
Gene Kakaulin
Co-Founder & Director
|
|||
2 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
